Semaglutide is a prescription medication that belongs to the GLP-1 receptor agonist class. FDA-approved semaglutide products are used for specific medical indications, including chronic weight management with Wegovy® and type 2 diabetes with Ozempic®.
A medically supervised weight-management program may combine prescription medication, nutrition guidance, physical activity recommendations, and regular weight monitoring.
Dreams Beauty Med Spa's suggested program structure:
Prescription evaluation by a qualified healthcare professional
Weekly semaglutide administration according to the patient's prescription
Weekly weight and progress check-ins
Monitoring for medication tolerance and side effects
Lifestyle and nutrition support
Dose adjustments only when clinically appropriate and prescribed
Ongoing progress tracking
Semaglutide treatment should be individualized. FDA-approved Wegovy injection is initiated at 0.25 mg once weekly and titrated at four-week intervals; the recommended maintenance doses for weight reduction are 1.7 mg or 2.4 mg once weekly. The 2.4 mg dose is the recommended maintenance dose for adults with obesity or overweight with a weight-related condition.
Prescription medication. Use only under the supervision of a qualified healthcare professional.
For FDA-approved Wegovy injection, semaglutide is administered subcutaneously once weekly, on the same day each week, in the abdomen, thigh, or upper arm. It may be administered with or without food. The dose is gradually increased to improve tolerability.
For compounded semaglutide, the prescribing clinician and dispensing pharmacy must provide the exact dose in mg and the corresponding volume in mL or syringe units based on the specific concentration.
Semaglutide is a prescription medication that belongs to the GLP-1 receptor agonist class. FDA-approved semaglutide products are used for specific medical indications, including chronic weight management with Wegovy® and type 2 diabetes with Ozempic®.
A medically supervised weight-management program may combine prescription medication, nutrition guidance, physical activity recommendations, and regular weight monitoring.
Dreams Beauty Med Spa's suggested program structure:
Prescription evaluation by a qualified healthcare professional
Weekly semaglutide administration according to the patient's prescription
Weekly weight and progress check-ins
Monitoring for medication tolerance and side effects
Lifestyle and nutrition support
Dose adjustments only when clinically appropriate and prescribed
Ongoing progress tracking
Semaglutide treatment should be individualized. FDA-approved Wegovy injection is initiated at 0.25 mg once weekly and titrated at four-week intervals; the recommended maintenance doses for weight reduction are 1.7 mg or 2.4 mg once weekly. The 2.4 mg dose is the recommended maintenance dose for adults with obesity or overweight with a weight-related condition.
Prescription medication. Use only under the supervision of a qualified healthcare professional.
For FDA-approved Wegovy injection, semaglutide is administered subcutaneously once weekly, on the same day each week, in the abdomen, thigh, or upper arm. It may be administered with or without food. The dose is gradually increased to improve tolerability.
For compounded semaglutide, the prescribing clinician and dispensing pharmacy must provide the exact dose in mg and the corresponding volume in mL or syringe units based on the specific concentration.
